Histologic transformation of follicular lymphoma: pathologists’ viewpoint
Journal of Clinical and Experimental Hematopathology · 2023
DOI: 10.3960/jslrt.22046 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2023. Verfasst von Akiko Miyagi Maeshima. Beteiligte Einrichtung: Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Plasmablastic Lymphoma, Lymphoma, Large-Cell, Anaplastic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Outcomes of patients with histologic transformation (HT) of follicular lymphoma (FL) have been believed to be poor. The most common histologic subtype of transformation from FL is diffuse large B-cell lymphoma (DLBCL), which accounts for 90% of the cases, and the remaining 10% of the cases include classic Hodgkin lymphoma, high-grade B-cell lymphoma, plasmablastic lymphoma, B-acute lymphoblastic leukemia/lymphoma, histiocytic/dendritic cell sarcoma, and anaplastic large cell lymphoma-like lymphoma. Because the histologic criteria for the diagnosis of DLBCL transformed from FL are unclear, convenient histopathological criteria for HT are required. One of the proposed criteria of HT from our institute is the presence of diffuse architecture with a proportion of large lymphoma cells of ≥20%, and for challenging cases, Ki-67 index ≥50% is used as a reference. Patients with HT to non-DLBCL have poorer outcomes than those with HT to DLBCL; thus, rapid and accurate histologic diagnosis is desired. In this review, we discussed the recent literatures describing the histopathologic variety and proposal of definition of HT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
Zitieren
APA
Maeshima, A. M. (2023). Histologic transformation of follicular lymphoma: pathologists’ viewpoint. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.22046
Vancouver
Maeshima AM. Histologic transformation of follicular lymphoma: pathologists’ viewpoint. Journal of Clinical and Experimental Hematopathology. 2023. doi:10.3960/jslrt.22046
BibTeX
@article{Maeshima2023,
author = {Maeshima, Akiko Miyagi},
title = {Histologic transformation of follicular lymphoma: pathologists’ viewpoint},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2023},
doi = {10.3960/jslrt.22046}
}
EUVIMED